Skip to main content
Skip to "About government"
Language selection
Français
Government of Canada /
Gouvernement du Canada
Search
Search the website
Search
Menu
Main
Menu
Jobs and the workplace
Immigration and citizenship
Travel and tourism
Business and industry
Benefits
Health
Taxes
Environment and natural resources
National security and defence
Culture, history and sport
Policing, justice and emergencies
Transport and infrastructure
Canada and the world
Money and finances
Science and innovation
You are here:
Canada.ca
Library and Archives Canada
Services
Services for galleries, libraries, archives and museums (GLAMs)
Theses Canada
Item – Theses Canada
Page Content
Item – Theses Canada
OCLC number
1032890115
Link(s) to full text
LAC copy
Author
Baerwald, Angela Renee.
Title
Human Ovarian Follicular Dynamics During Natural Menstrual Cycles and Oral Contraception Cycles.
Degree
Ph. D. -- University of Saskatchewan, 2008
Publisher
Saskatoon : University of Saskatchewan, 2008.
Description
1 online resource
Notes
Includes bibliographical references.
Unrestricted.
I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to University of Saskatchewan or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.
Abstract
The objective of the research comprising this thesis was to characterize ovarian follicular development in healthy women of reproductive age undergoing natural menstrual cycles and oral contraception (DC) cycles. We quantified changes in the numbers and diameters of follicles, detected ovulation and assessed changes in the growth and regression of corpora lutea using high-resolution transvaginal ultrasonography. Changes in follicular and luteal development were then correlated with changes in concentrations of reproductively-active hormones and endometrial growth to provide a comprehensive approach to ovarian and uterine function. We documented, for the first time, that women exhibited waves of antral follicular development during the menstrual cycle. Two and three waves of follicle growth were observed. Major and minor waves of follicle development were characterized. Major waves were those in which a dominant follicle was selected for preferential growth; minor waves were those in which dominance was not manifest. Luteal progesterone production appeared to have a negative effect on the emergence and development of follicle waves in women. The ovarian follicular wave phenomenon has provided a new model for studying the growth and regression of ovarian follicles during the human menstrual cycle. Documentation of ovarian follicular waves in women has implications for the development of new strategies to manipulate ovarian follicular development, in particular hormonal contraceptive regimens and infertility therapies. We further documented that ovarian follicular development occurred during the compliant use of oral contraception. Follicles developed to ostensibly ovulatory diameters, and either regressed, ovulated or formed follicular cysts under the suppressive effects of DC. The majority of follicles that developed during DC use emerged during the hormone-free interval (HFI). We interpreted our findings to mean that ovarian follicular development during DC use was associated with loss of endocrine suppression during the HFI, rather than user non-compliance as previously speculated. The number and maximum diameter of follicles that developed during DC use were greater in women administered DC containing 20 ♯g versus 30-35 ♯g Ethinyl Estradiol formulations. Our results provided rationale for a reduction or complete elimination of the HFI in OC regimens, and the judicious use of low EE dose OC regimens (ie., <u><</u> 20 ♯g EE). Ovarian follicular development and circulating concentrations of estradiol and LH were not suppressed effectively when OC use was initiated at mid to late stages of follicle development (i.e., <u>></u> 10 mm). Our findings demonstrated that dominant follicles secrete estradiol and become increasingly responsive to LH as they acquire functional dominance after becoming physiologically selected for preferential growth during the follicular phase of the menstrual cycle.
Other link(s)
library.usask.ca
Subject
none.
Date modified:
2022-09-01